These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1971640)

  • 21. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Chen CH; Lin CH; Lin JS
    Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e26. PubMed ID: 28591254
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
    Bonatti H; Guggenbichler JP; Hager J
    Infection; 1990; 18(5):302-6. PubMed ID: 2276826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections].
    Hou F; Wu G; Zheng B
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):589-93. PubMed ID: 11758237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy and safety of imipenem/cilastatin in the treatment of complicated urinary tract infections.
    Goldoni S; Gandolfi P; Tubaro A; Vicentini C; Lancione P; Miano L
    J Chemother; 1989 Jul; 1(4 Suppl):845-7. PubMed ID: 16312665
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the perinatal period].
    Ito K; Izumi K; Takagi H; Tamaya T; Hayasaki M
    Jpn J Antibiot; 1988 Nov; 41(11):1778-85. PubMed ID: 3210308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical study of imipenem/cilastatin in the treatment of generalized and localized infections.
    Tigano F; D'Ambrosio FP; Angio LG
    J Chemother; 1989 Jul; 1(4 Suppl):638-40. PubMed ID: 16312569
    [No Abstract]   [Full Text] [Related]  

  • 28. [Imipenem-cilastatin in nosocomial infections in HIV+ patients].
    Pagano G; Repetto T; Ferrazin A; Canessa A; Carrega G
    G Ital Chemioter; 1991; 38(1-3):191-2. PubMed ID: 1365589
    [No Abstract]   [Full Text] [Related]  

  • 29. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.
    Fabian TC; File TM; Embil JM; Krige JE; Klein S; Rose A; Melnick D; Soto NE
    Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
    Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
    Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multicenter comparative study of meropenem vs. imipenem in the intramuscular treatment of hospital infections of the urinary tract].
    Tallarigo C; Comunale L; Baldassarre R; Poletti G
    Minerva Urol Nefrol; 1995 Sep; 47(3):147-56. PubMed ID: 8815553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
    Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
    Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A; Meli EZ; Mazzocchi P; Speranza V
    Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of sodium imipenem/cilastatin on patients of complicated urinary tract infections--following the failure of prior antimicrobial agents].
    Yoshida K; Kobayashi N; Tohsaka A; Uchijima Y; Takeuchi S; Saitoh H; Negishi T; Yamada T; Nagamatsu H; Masuda H
    Hinyokika Kiyo; 1992 Apr; 38(4):495-9. PubMed ID: 1529826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
    Freire AT; Melnyk V; Kim MJ; Datsenko O; Dzyublik O; Glumcher F; Chuang YC; Maroko RT; Dukart G; Cooper CA; Korth-Bradley JM; Dartois N; Gandjini H;
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):140-51. PubMed ID: 20846586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overall clinical utility of the intramuscular preparation of imipenem/cilastatin.
    MacGregor RR
    Chemotherapy; 1991; 37 Suppl 2():53-7. PubMed ID: 1879188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of antimicrobial drugs in adults before and after removal of a restriction policy.
    Himmelberg CJ; Pleasants RA; Weber DJ; Kessler JM; Samsa GP; Spivey JM; Morris TL
    Am J Hosp Pharm; 1991 Jun; 48(6):1220-7. PubMed ID: 1858800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic and clinical studies on imipenem/cilastatin sodium in the perinatal period. A study of imipenem/cilastatin sodium in the perinatal co-research group].
    Matsuda S; Suzuki M; Oh K; Ishikawa M; Soma A; Takada H; Shimizu T; Makinoda S; Fujimoto S; Chimura T
    Jpn J Antibiot; 1988 Nov; 41(11):1731-41. PubMed ID: 3062205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial agents in neutropenic patients with unexplained fever.
    Shevchuk YM
    J Infect Dis; 1991 Jan; 163(1):203. PubMed ID: 1984471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.